GlassScriptPhysician profile
Kristin Davidson
NPI 1720462633
$2,012.26
in general payments reported to CMS, 2019-2025
18 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $558 · 2022: $403 · 2023: $393 · 2024: $315 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.22 |
| Education | $155.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $506.96 | 2021-2023 | |
| Astellas Pharma US INC | $338.55 | 2023-2024 | Veozah |
| Therapeuticsmd, INC. | $264.01 | 2021-2022 | |
| Hologic Sales and Service, LLC | $259.92 | 2023-2025 | Novasure, Aptima, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $223.50 | 2022-2025 | Annovera, Nextstellis |
| Exeltis, USA INC. | $74.29 | 2022-2024 | Slynd |
| Pfizer INC. | $58.69 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $51.80 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $50.28 | 2021-2025 | |
| Daiichi Sankyo INC. | $37.64 | 2021 | |
| Sage Therapeutics, LLC | $30.66 | 2024-2025 | Zurzuvae |
| Convatec INC. | $20.49 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.48 | 2022 | |
| Organon LLC | $17.07 | 2024 | |
| Myovant Sciences INC. | $16.96 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $16.40 | 2022 | |
| Supernus Pharmaceuticals, INC. | $14.70 | 2025 | Qelbree |
| Avion Pharmaceuticals | $12.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.